QQ客服 官方微博 反馈留言

	Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation
	Zhang Jingjing[1]; Ding Lili[2]; Wang Baocan[3]; Ren Gaiyan[4]; Sun Aning[5]; Deng Chao[6]; Wei Xiaohui[7]; Mani Sridhar[8]; Wang Zhengtao[9]; Dou Wei[10]
刊名	The Journal of pharmacology and experimental therapeutics
	2015
卷号	352页码:315-24
ISSN号	1521-0103
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2268228
专题	上海大学
作者单位	1.[1]Shanghai Key Laboratory of Complex Prescription and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China 2.Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China 3.and Departments of Medicine and Genetics, Albert Einstein College of Medicine, Bronx, New York . 4.[2]Shanghai Key Laboratory of Complex Prescription and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China 5.Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China 6.and Departments of Medicine and Genetics, Albert Einstein College of Medicine, Bronx, New York . 7.[3]Shanghai Key Laboratory of Complex Prescription and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China 8.Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China 9.and Departments of Medicine and Genetics, Albert Einstein College of Medicine, Bronx, New York . 10.[4]Shanghai Key Laboratory of Complex Prescription and MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, China
推荐引用方式 GB/T 7714	Zhang Jingjing[1],Ding Lili[2],Wang Baocan[3],et al. Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation[J]. The Journal of pharmacology and experimental therapeutics,2015,352:315-24.
APA	Zhang Jingjing[1].,Ding Lili[2].,Wang Baocan[3].,Ren Gaiyan[4].,Sun Aning[5].,...&Dou Wei[10].(2015).Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation.The Journal of pharmacology and experimental therapeutics,352,315-24.
MLA	Zhang Jingjing[1],et al."Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation".The Journal of pharmacology and experimental therapeutics 352(2015):315-24.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。